期刊文献+

B群链球菌对红霉素及克林霉素耐药机制研究 被引量:12

The study of resistance mechanisms for group B Streptococcus to erythromycin and cli ndamycin
下载PDF
导出
摘要 目的研究东莞地区孕产妇携带的GBS对大环内酯类的主要耐药表型及对红霉素、克林霉素的耐药机制。方法采用D试验筛查51株孕产妇携带的GBS对大环内酯类耐药表型;采用PCR方法检测GBS红霉素耐药基因erm TR、erm B、mef A/E及克林霉素耐药基因lin B,进行基因测序及BLAST序列比对分析。结果 51株GBS经D试验筛查,35株为c MLSB耐药表型,7株为M耐药表型,9株为L耐药表型,未检测到i MLSB耐药表型;PCR检测到erm B 40株、mef A/E 23株、lin B 5株,未检测到erm TR耐药基因;c MLSB耐药表型中37.14%(13/35)GBS同时检出erm B和mef A/E基因。结论 东莞地区孕产妇携带的GBS菌株大环内酯类耐药表型以c MLSB为主;erm B编码的23S r RNA甲基化酶是介导红霉素耐药的主要耐药机制;检测到新型耐药基因lin B。东莞地区c MLSB耐药表型高而M耐药表型低,提示克林霉素作为预防和治疗GBS感染的二线药物在该地区可能会受到一定的限制。 Objective The purpose of this investigation was to analyse Maternal carry GBS isolates collected in Dongguan in respect to their macrolide resistence phenotypes, erythromycin and clindamycin resistence mechanisms. Methods All 51 isolates were detected by D-trials for macrolide resistance phenotypes, The presence of erythromyein, clindamycin resistance gene such as ermTR, ermB, mefA/E, linB were determined by PCR amplification and analysed by sequencing. Results Of 51 GBS strains were tested by D-trials, there were 35 cMLSB, 7M, 9 L resistant phenotype, iMLSB resistant phenotype was not detected; 40 isolates harboured ermB genes, 23 isolates harboured mefA/E genes, linB gene was deteced in 5 strains, there were a failure to amplify ermTR genes by PCR. 37.14% of the strains exhibited a combination of ermB and mefA/E genes in cMLSa phenotypes. Conclusion In our study, there was a predominance of cMLSB phenotypes, indicating that erythromycin resistance was mediated by the principal methylation of 23S ribosomal RNA. The linB genes were detected. Clindamycin should not be recommended as the second-line antimicrobial in Dongguan city.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2015年第2期124-127,共4页 Chinese Journal of Antibiotics
关键词 B群链球菌 红霉素 克林霉素 耐药基因 Group B streptococci Erythromycin Clindamycin Resistance genes
  • 相关文献

参考文献13

  • 1Verani J R, McGee L, Schrag S J, et al. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010[J]. MMWR Reeomm Rep, 2010, 59(RR- 10): 1-36.
  • 2Capannaa F, Emonet S P, Cherkaoui A, et al. Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis[J]. Swiss Med Wkly, 2013, 143: w13778.
  • 3Back E E, O'Grady E J, Back J D. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital[J]. Antimicrob Agents Chemother, 2012, 56: 739-742.
  • 4Arisoy A S, Altinisik B, Tunger O, et al. Maternal carriage and antimicrobial resistance profile of group B Streptococcus[J]. Infection, 2003, 31: 244-246.
  • 5Arpin C, Daube H, Tessier F, et al. Presence of mefA and mefE genes in Streptococcus agalactiae[J]. Antimicrob Agents Chemother, 1999, 43: 944-946.
  • 6Dela Cruz W P, Richardson J Y, Broestler J M, et aL Rapid determination of macrolide and L incosamide resistance in Group B Streptococcus isolated from vaginal-rectal swabs[J]. Infect Dis Obst Gynecol, 2007, 2007: 46581.
  • 7Acikgoz Z C, Almayanlar E, Gamberzade S, et aL Macrolideresistance determinants of invasive and noninvasive group B streptococci in a Turkish hospital[J]. Antimicrob Agents Chemother, 2004, 48: 1410-1412.
  • 8De Francesco M A, Caracciolo S, Gargiulo F, et al. Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy[J]. Eur J Clin Microbiol Infect Dis , 2012, 31: 1741-1747.
  • 9Lu B H, Li D, Cui Y C, et al. Epidemiology of group B Streptococcus isolated from pregnant women in Beijing, China[J]. Clin Microbiollnfeet, 2013, 10. 1111/1469-0691. 12416.
  • 10Nakamura P A, B Schuab R B, Neves F P, et al. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae[J]. Mem Inst Oswaldo Cruz, 2011, 106(2): 119-122.

同被引文献78

  • 1朱敏,范建霞,程利南.围产期B族链球菌感染的研究进展[J].中华妇产科杂志,2005,40(2):137-141. 被引量:110
  • 2应群华,严文卫,丁金龙.围产期生殖道菌群检测和B群链球菌筛查[J].中国微生态学杂志,2006,18(6):491-492. 被引量:28
  • 3赵红庆,苑锡铜,黄留玉.多重PCR技术在病原检测中的应用[J].生物技术通讯,2007,18(5):863-865. 被引量:51
  • 4Verani J R, McGee L, Schrag S J, et al. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010[J]. MMWR Recomm Rep, 2010, 59(RR- 10): 1-36.
  • 5Maiden M C. Multilocus sequence typing of bacteria[J].Annu Rev Microbiol, 2006, 60(1): 561-588.
  • 6Urwin R, Maiden M C J. Multilocus sequence typing: a tool for global epidemiology[J]. Trends Microbiol, 2003, 11 (10): 479-487.
  • 7Jones N, Bohnsack J F, Takahashi S, et al. Multilocus sequence typing system for group B Streptococcus[J]. Clin Microbiol, 2003, 41(6): 2530-2536.
  • 8Feil E J, Li B C, Aanensen D M, et al. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data[J] Bacteriol, 2004, 186(5 ): 1518-1530.
  • 9Capannaa F, Emonet S P, Cherkaoui A, el al. Antibiotic resistance patterns among group B Streptococcus isolates implications for antibiotic prophylaxis for early-onset neonatal sepsis[J]. Swiss Med Wkly, 2013, 143:w13778.
  • 10Back E E, O'Grady E J, Back J D. High rates of perinatal group B Streptococcus clindamycin and erythromycin resistance in an upstate New York hospital[J]. Antimicrob Agents Chemother, 2012, 56(2): 739-742.

引证文献12

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部